Investigative Ophthalmology & Visual Science Cover Image for Volume 52, Issue 12
November 2011
Volume 52, Issue 12
Free
Multidisciplinary Ophthalmic Imaging  |   November 2011
Ocular Surface Epithelial Thickness Evaluation with Spectral-Domain Optical Coherence Tomography
Author Affiliations & Notes
  • Marlène Francoz
    From the Department of Ophthalmology III, and
    Center of Clinical Investigations (CIC) 503, Quinze-Vingts National Ophthalmology Hospital, Paris, France;
    Department of Ophthalmology, Hôpital Nord, CHU de Saint-Etienne, Université Jean-Monnet, Saint-Etienne cedex 2, France;
  • Issouf Karamoko
    From the Department of Ophthalmology III, and
    Center of Clinical Investigations (CIC) 503, Quinze-Vingts National Ophthalmology Hospital, Paris, France;
  • Christophe Baudouin
    From the Department of Ophthalmology III, and
    Center of Clinical Investigations (CIC) 503, Quinze-Vingts National Ophthalmology Hospital, Paris, France;
    Department of Ophthalmology, Ambroise Paré Hospital, APHP, University of Versailles Saint-Quentin en Yvelines, Versailles, France;
    INSERM, U968, Université Pierre et Marie Curie Paris 6, UMR S 968, Institut de la Vision, CNRS, UMR 7210, Paris, France.
  • Antoine Labbé
    From the Department of Ophthalmology III, and
    Center of Clinical Investigations (CIC) 503, Quinze-Vingts National Ophthalmology Hospital, Paris, France;
    Department of Ophthalmology, Ambroise Paré Hospital, APHP, University of Versailles Saint-Quentin en Yvelines, Versailles, France;
    INSERM, U968, Université Pierre et Marie Curie Paris 6, UMR S 968, Institut de la Vision, CNRS, UMR 7210, Paris, France.
  • Corresponding author: Antoine Labbé, Service d'Ophtalmologie III, C.H.N.O. des Quinze-Vingts, 28 rue de Charenton, 75012 Paris, France; [email protected]
Investigative Ophthalmology & Visual Science November 2011, Vol.52, 9116-9123. doi:https://doi.org/10.1167/iovs.11-7988
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marlène Francoz, Issouf Karamoko, Christophe Baudouin, Antoine Labbé; Ocular Surface Epithelial Thickness Evaluation with Spectral-Domain Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 2011;52(12):9116-9123. https://doi.org/10.1167/iovs.11-7988.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose.: To use in vivo spectral-domain optical coherence tomography (SD-OCT) to measure corneal, limbal, and bulbar conjunctival epithelial thickness.

Methods.: A total of 156 eyes of 79 subjects were enrolled in four groups: young control (YC group), < 40 years; middle-aged control (MAC group), > 40 years; patients with dry eye syndrome (KCS group); and patients with glaucoma or ocular hypertension treated with intraocular pressure (IOP)-lowering medication (G group). The central corneal epithelium (CE) thickness, and the limbal (LE) and bulbar conjunctival epithelium (BCE) thickness in four quadrants were measured using SD-OCT.

Results.: The mean thicknesses of the CE, LE, and BCE of the YC group were 48.3 ± 2.9 μm, 83.0 ± 14.3 μm, and 42.0 ± 7.5 μm, and for the MAC group were 48.8 ± 3.0 μm, 84.3 ± 10.1 μm, and 42.2 ± 7.9 μm, respectively. The ocular surface epithelial thickness was not significantly different between the YC and MAC groups. CE thicknesses were not significantly different between the KCS, G, and control groups. The mean LE thicknesses were significantly lower in the KCS and G groups compared with the MAC group. The mean BCE was significantly thicker in the KCS and G groups compared with the MAC group.

Conclusions.: Anterior segment SD-OCT can provide a noninvasive evaluation of ocular surface epithelial thickness. LE and BCE thickness was modified in dry eye patients and patients using IOP-lowering eye drops, whereas aging seemed to have no effect.

The evaluation of ocular surface epithelia remains a challenge for clinicians and researchers. In clinical practice, evaluation is limited by the resolution of the biomicroscope and by the variability of ocular surface tests. 1 Histologic ex vivo techniques, such as brush cytology or impression cytology, have been introduced to improve clinical and experimental evaluation of the surface epithelia. 2 More recently, imaging techniques such as in vivo confocal microscopy (IVCM) have enabled a minimally invasive, almost histologic analysis, of ocular surface epithelia. 3 These methods have provided many advances in the exploration of the normal eye and eyes with ocular surface diseases, such as dry eye, 3 allergic conjunctivitis, or eye drop and preservative toxicity. 4 However, the techniques are either invasive or require contact between a probe and the ocular tissues, and cannot provide precise in vivo measurement of epithelial thickness. 5  
Optical coherence tomography (OCT) is an in vivo, noncontact technique for obtaining high-resolution, cross-sectional imaging of biological tissues via measuring optical reflections. 6 Recently, the utility of OCT in clinical practice has extended to the anterior segment of the eye. OCT is a practical and reliable instrument for measuring corneal thickness, and several studies have already used this technique to measure corneal epithelial thickness in vivo in humans. 7 14 To our knowledge, only one publication has evaluated the conjunctival and limbal epithelial thickness using time domain OCT in healthy eyes. 15  
Recent progress in OCT technology with spectral-domain optical coherence tomography (SD-OCT) has increased imaging speed, and consequently increased image resolution. The objective of the present study was to use in vivo SD-OCT to compare the corneal, limbal, and bulbar conjunctival epithelial thickness in normal eyes and eyes with ocular surface disease. 
Patients and Methods
Subjects
A total of 156 eyes of 79 subjects were consecutively enrolled from July to November 2010. This study was performed at the Center of Clinical Investigations (CIC 503) at the Quinze-Vingts National Ophthalmology Hospital, with the approval of the Institutional Review Board of Saint-Antoine University Hospital (CPP-Ile de France 5, number 10,793), and in accord with the Declaration of Helsinki. All subjects were informed of the aims of the study, and their consent was obtained. 
Fifty-five eyes of 28 healthy volunteers were enrolled. The young control (YC) group comprised subjects aged < 40 years (n = 18 subjects; nine women and nine men; mean age 28.5 ± 6.5 years; range 20 to 39 years). The middle-aged control (MAC) group comprised subjects aged > 40 years (n = 10 subjects; four women and six men; mean age 53.3 ± 8.6 years; range 41 to 66 years). All healthy volunteers (YC and MAC groups) had no complaint of ocular surface irritation, and no anterior segment abnormality on biomicroscopic examination and ocular surface tests. Fifty-six eyes of 28 patients with dry eye syndrome (keratoconjunctivitis sicca [KCS] group) were enrolled. The KCS group comprised three patients with Sjögren syndrome dry eye and 25 patients with non-Sjögren syndrome dry eye (24 women and four men; mean age 58.5 ± 13.7 years; range 26 to 81 years). Dry eye was defined as a Schirmer 1 testing < 10 mm, interpalpebral ocular surface fluorescein staining (at least 2 on the Oxford scheme), and tear film instability accompanied by complaints of ocular irritation. 1 Forty-five eyes of 23 patients with glaucoma or ocular hypertension treated with intraocular pressure (IOP)-lowering medications were enrolled. The glaucoma group (G) comprised 13 women and 10 men with a mean age of 53.9 ± 14.0 years (range 25 to 78 years). Exclusion criteria for all groups were: age < 18 years, subject unable to complete the questionnaire or understand the procedures, current or use within the last 6 months of eye drops (other than nonpreserved tear substitutes for the KCS group, and antiglaucoma medications for the G group), a change in the antiglaucomatous topical regimen within the last 6 months, previous eye surgery, contact lens wear, and a local or systemic disease or treatment that could influence the ocular surface. 
Ophthalmologic Examination
Demographic information and medical history was obtained from the patients' medical records. Each subject was asked to complete the Ocular Surface Disease Index (OSDI) questionnaire. 16 Then, all patients underwent a complete examination of the ocular surface in both eyes in the following order: tear film break-up time (TBUT), corneal and conjunctival fluorescein staining using the Oxford scheme, and Schirmer test without anesthesia. 1 Finally, according to the 2007 Dry Eye Workshop, a severity grading scheme (1–4) was used to evaluate symptoms and signs of ocular surface disease. 17  
OCT Examination and Image Analysis
An SD-OCT fitted with an anterior segment module (Spectralis OCT, Heidelberg Engineering GmbH, Heidelberg, Germany) was used. The OCT axial and lateral optical resolutions were 3.9 μm and 11 μm, respectively. All acquisitions were taken using the high-resolution mode with an acquisition time of 19 ms per image. The instrument combines OCT technology with a confocal scanning laser ophthalmoscope (cSLO) to provide a live view of the eye to control the location of the OCT scan. Because OCT is a noncontact technique, it was performed before the ophthalmologic examination and ocular surface tests to avoid potential artifacts. For each eye, one image of the central cornea and one image of the limbo-conjunctival area in each quadrant (superior, inferior, temporal, and nasal) were analyzed. A horizontal scan was used for imaging the central cornea, and the nasal and temporal limbus and conjunctival areas, whereas a vertical scan was used for the inferior and superior limbus and conjunctival areas. 
The images were analyzed with a zoom factor of 600% to 800% provided by the SD-OCT software (Spectralis OCT; Heidelberg Engineering GmbH) with a resolution of 3.87 μm/pixel axially and 11.1 μm/pixel laterally. 
The central corneal epithelium (CE) thickness, the limbal epithelium (LE) thickness, and the bulbar conjunctival epithelial (BCE) thickness, between 2 and 3 mm from the limbus of each quadrant, were measured using the cursors provided by the SD-OCT software (Fig. 1). The cursors were placed perpendicular to the ocular surface epithelium from a point located just beneath the tear film (first hyperreflective layer) to the basal membrane (second hyperreflective layer). For each quadrant, three measures were obtained, and results were expressed as mean ± SD. All measurements were made by one examiner (MF) who was masked to the subject's ophthalmologic examination and status. To evaluate interobserver variability, a second examiner (IK) who was masked to the first measurements, evaluated the CE, LE, and BCE from the same images obtained on 19 randomized eyes. A Wilcoxon paired test demonstrated no significant differences between the two examiners. 
Figure 1.
 
SD-OCT images of ocular surface epithelia. (A–C) CE analysis. (A) Live cSLO image of the central cornea with the horizontal scan mark; (B) corresponding SD-OCT (B-scan); the white rectangle shows the area analyzed; (C) CE thickness measurement with software cursors, the tear film appears hyperreflective (white arrow) and the basal epithelial membrane appeared hyperreflective (black arrow). (D–F) Limbal epithelium (LE) analysis. (D) Live cSLO image, the black arrow marks the vertical line on SD-OCT; (E) corresponding SD-OCT image; the vertical line was centered on the limbus through the scleral spur; (F) LE thickness measures. (G–I) BCE analysis. (G) Live cSLO image; (H) corresponding SD-OCT image; the white rectangle shows the bulbar conjunctival zone between 2 and 3 mm from limbus (vertical line); (I) BCE thickness measures.
Figure 1.
 
SD-OCT images of ocular surface epithelia. (A–C) CE analysis. (A) Live cSLO image of the central cornea with the horizontal scan mark; (B) corresponding SD-OCT (B-scan); the white rectangle shows the area analyzed; (C) CE thickness measurement with software cursors, the tear film appears hyperreflective (white arrow) and the basal epithelial membrane appeared hyperreflective (black arrow). (D–F) Limbal epithelium (LE) analysis. (D) Live cSLO image, the black arrow marks the vertical line on SD-OCT; (E) corresponding SD-OCT image; the vertical line was centered on the limbus through the scleral spur; (F) LE thickness measures. (G–I) BCE analysis. (G) Live cSLO image; (H) corresponding SD-OCT image; the white rectangle shows the bulbar conjunctival zone between 2 and 3 mm from limbus (vertical line); (I) BCE thickness measures.
Statistical Analysis
Results for the descriptive statistics are presented as the mean ± SD. Simple comparisons between groups were performed using the nonparametric Mann-Whitney U test, and comparisons between several groups were performed using the Kruskal-Wallis test. The correlations between the different variables were studied using Spearman's correlation coefficient. Probability values < 0.05 were considered significant. All statistical analyses were performed using statistical software (XLSTAT 2010; Addinsoft, Paris, France). 
Results
Corneal, Limbal, and Conjunctival Epithelia in Healthy Eyes
Between Group Comparisons.
The mean thicknesses of the CE, LE, and BCE of the YC group were 48.3 ± 2.9 μm, 83.0 ± 14.3 μm, and 42.0 ± 7.5 μm, and for the MAC group 48.8 ± 3.0 μm, 84.3 ± 10.1 μm, and 42.2 ± 7.9 μm, respectively. In both groups, the thickest epithelium was the LE followed by the CE (P < 0.0001 in both groups compared with LE) and BCE (P = 0.003 in YC and P = 0.019 in MAC compared with CE). The CE, LE, and BCE measured in the YC and MAC groups were not statistically significantly different between groups. Similarly, no statistical correlations between CE, LE, or BCE and age were observed. Results are presented in Figure 2 and Table 1
Figure 2.
 
Comparisons between CE, LE, and BCE thicknesses in YC group and MAC group. In both groups, the thickest epithelium was the LE followed by the CE (***P < 0.0001 in both groups, comparing LE with CE) and BCE (*P = 0.003 in YC and **P = 0.019 in MAC comparing BCE with CE). There was no statistical difference in CE, LE, and BCE thickness between the YC and MAC groups.
Figure 2.
 
Comparisons between CE, LE, and BCE thicknesses in YC group and MAC group. In both groups, the thickest epithelium was the LE followed by the CE (***P < 0.0001 in both groups, comparing LE with CE) and BCE (*P = 0.003 in YC and **P = 0.019 in MAC comparing BCE with CE). There was no statistical difference in CE, LE, and BCE thickness between the YC and MAC groups.
Table 1.
 
Ocular Surface Epithelium Thickness (μm) in Normal Eyes, in Dry Eyes (KCS Group), and in Eyes Treated Chronically with IOP-Lowering Eyedrops (G group)
Table 1.
 
Ocular Surface Epithelium Thickness (μm) in Normal Eyes, in Dry Eyes (KCS Group), and in Eyes Treated Chronically with IOP-Lowering Eyedrops (G group)
Ocular Surface Epithelium Young Controls Middle-Aged Controls KCS G
CE 48.3 ± 2.9 48.8 ± 3.0 49.0 ± 4.1 50.3 ± 5.7
LE 83.0 ± 14.3 84.3 ± 10.1 77.3 ± 17.2 73.3 ± 10.5
Nasal 67.9 ± 10.7 67.9 ± 7.5 65.0 ± 14.9 68.0 ± 16.1
Temporal 69.3 ± 14.5 66.9 ± 11.9 63.6 ± 15.0 62.4 ± 13.6
Inferior 98.0 ± 23.7 106.8 ± 20.0 86.1 ± 21.6 80.3 ± 20.1
Superior 95.6 ± 15.0 97.2 ± 11.1 95.9 ± 35.4 83.9 ± 18.4
BCE 42.0 ± 7.5 42.2 ± 7.9 50.4 ± 11.1 49.5 ± 11.0
Nasal 41.1 ± 8.2 39.1 ± 9.1 46.3 ± 11.0 48.2 ± 12.4
Temporal 38.3 ± 7.7 41.3 ± 9.8 43.6 ± 11.6 44.6 ± 10.1
Inferior 47.3 ± 11.9 47.7 ± 15.0 55.2 ± 9.6 53.9 ± 14.3
Superior 40.4 ± 8.9 43.6 ± 11.7 58.0 ± 27.5 53.2 ± 19.5
Quadrant Comparisons.
In both control groups, the LE in the superior and inferior quadrants (95.6 ± 15.0 μm and 98.0 ± 23.7 μm in YC; 97.2 ± 11.1 μm and 106.8 ± 20.0 μm in MAC; respectively) were thicker than in the nasal and temporal quadrants (67.9 ± 10.7 μm and 69.3 ± 14.5 μm in YC; 67.9 ± 7.5 μm and 66.9 ± 11.9 μm in MAC, respectively; P < 0.0001 for all comparisons). For each limbal area, there was no difference between the YC and MAC groups. Results are presented in Figure 3
Figure 3.
 
LE thickness in each quadrant in YC and MAC groups. In the YC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001). In the MAC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001).
Figure 3.
 
LE thickness in each quadrant in YC and MAC groups. In the YC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001). In the MAC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001).
In the YC group, the BCE was significantly thicker in the inferior quadrant (47.3 ± 11.9 μm) compared with the nasal (41.1 ± 8.2 μm; P = 0.03), temporal (38.3 ± 7.7 μm; P < 0.0001), and superior (40.4 ± 8.9 μm; P = 0.009) quadrants. In the MAC group, there was no significant difference in the epithelial thickness between the four BCE quadrants (nasal, temporal, inferior, and superior: 39.1 ± 9.1 μm, 41.3 ± 9.8 μm, 47.7 ± 15.0 μm, and 43.6 ± 11.7 μm, respectively). For each quadrant, there was no significant difference in BCE thickness between the YC and MAC groups. Results are presented in Figure 4
Figure 4.
 
BCE thickness in each quadrant in YC and MAC groups. In the YC group, the BCE was thicker in the inferior quadrant (*P = 0.03 vs. nasal, P < 0.0001 vs. temporal, P = 0.009 vs. superior). In the MAC group, there was no significant difference between each quadrant.
Figure 4.
 
BCE thickness in each quadrant in YC and MAC groups. In the YC group, the BCE was thicker in the inferior quadrant (*P = 0.03 vs. nasal, P < 0.0001 vs. temporal, P = 0.009 vs. superior). In the MAC group, there was no significant difference between each quadrant.
Corneal, Limbal, and Conjunctival Epithelia in Ocular Surface Diseases
Between Group Comparisons.
Ocular surface epithelium of the KCS and G groups were only compared with the MAC group because these three groups were not different in terms of age (P = 0.237 and P = 0.979, MAC group vs. KCS and G groups, respectively). The mean thicknesses of the CE, LE, and BCE were 49.0 ± 4.1 μm, 77.3 ± 17.2 μm, and 50.4 ± 11.1 μm in the KCS group, respectively, and 50.3 ± 5.7 μm, 73.3 ± 10.5 μm, and 49.5 ± 11.0 μm in the G group, respectively. In both groups, the thickest epithelium was the LE (P < 0.0001 compared with CE and BCE for both groups), but no significant difference was observed between BCE and CE (P = 0.937 in the KCS group and P = 0.670 in the G group). The results are presented in Table 1 and Figure 5
Figure 5.
 
Comparison between mean CE, LE, and BCE thicknesses in KCS, G, and MAC groups. In the KCS and MAC groups, the thickest epithelium was the LE (+P < 0.0001 LE compared with CE and BCE). The mean LE was significantly thinner in the KCS group (*P = 0.031) and in the G group (**P = 0.001) compared with the MAC group. The mean BCE was thicker in the KCS group (†P = 0.005) and in the G group (‡P = 0.017) compared with the MAC group.
Figure 5.
 
Comparison between mean CE, LE, and BCE thicknesses in KCS, G, and MAC groups. In the KCS and MAC groups, the thickest epithelium was the LE (+P < 0.0001 LE compared with CE and BCE). The mean LE was significantly thinner in the KCS group (*P = 0.031) and in the G group (**P = 0.001) compared with the MAC group. The mean BCE was thicker in the KCS group (†P = 0.005) and in the G group (‡P = 0.017) compared with the MAC group.
There was no significant difference in CE thickness between the three groups. The mean LE thickness was significantly lower in the KCS and G groups compared with the MAC group (P = 0.031 compared with KCS and P = 0.001 compared with G) (Fig. 5). The mean BCE was significantly thicker in the KCS and G groups compared with the MAC group (P = 0.005 compared with KCS, and P = 0.017 compared with G) (Fig. 5). 
Quadrant Comparisons.
As in healthy subjects, the LE thickness was significantly higher in superior (95.9 ± 35.4 μm in KCS and 83.9 ± 18.4 μm in G) and inferior (86.1 ± 21.6 μm in KCS and 80.3 ± 20.1 μm in G) quadrants, compared with nasal (65.0 ± 14.9 μm in KCS and 68.0 ± 16.1 μm in G, P < 0.05 for all comparisons) and temporal (63.6 ± 15.0 μm in KCS and 62.4 ± 13.6 μm in G, P < 0.05 for all comparisons) quadrants. The inferior LE thickness was lower in the KCS and G groups compared with the MAC group (P = 0.0018 and P = 0.001, respectively). In the superior quadrant, the LE was significantly thinner in the G group compared with the MAC group (P = 0.008), but no significant difference was found between the KCS and MAC groups (P = 0.594) (Fig. 6). 
Figure 6.
 
LE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the LE was thicker in the inferior quadrant (+P = 0.026 vs. nasal and P < 0.0001 vs. temporal) and the superior quadrant (***P < 0.0001 vs. nasal and temporal). In the KCS group, the inferior LE was thinner than the inferior LE of the MAC group (‡P = 0.0018). In the G group, the LE was thicker in the inferior quadrant (**P < 0.0001 vs. nasal and temporal) and the superior quadrant (**P < 0.0001 vs. nasal and temporal). Compared with the MAC group, the G group had thinner LE in the inferior and superior quadrants (†P = 0.001 and P = 0.008 respectively). In the MAC group, the LE was thicker in the inferior quadrant (*P < 0.0001 vs. nasal and temporal) and the superior quadrant (*P < 0.0001 vs. nasal and temporal).
Figure 6.
 
LE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the LE was thicker in the inferior quadrant (+P = 0.026 vs. nasal and P < 0.0001 vs. temporal) and the superior quadrant (***P < 0.0001 vs. nasal and temporal). In the KCS group, the inferior LE was thinner than the inferior LE of the MAC group (‡P = 0.0018). In the G group, the LE was thicker in the inferior quadrant (**P < 0.0001 vs. nasal and temporal) and the superior quadrant (**P < 0.0001 vs. nasal and temporal). Compared with the MAC group, the G group had thinner LE in the inferior and superior quadrants (†P = 0.001 and P = 0.008 respectively). In the MAC group, the LE was thicker in the inferior quadrant (*P < 0.0001 vs. nasal and temporal) and the superior quadrant (*P < 0.0001 vs. nasal and temporal).
In patients with KCS, BCE thickness was significantly higher in the superior (58.0 ± 27.5 μm) compared with the nasal (46.3 ± 11.0 μm; P = 0.020) and temporal (43.6 ± 11.6 μm; P < 0.0001) quadrants, and also significantly higher in the inferior (55.2 ± 9.6 μm) compared with the nasal (P < 0.0001) and temporal (P < 0.0001) quadrants. Also in the KCS group, the BCE was significantly thicker in the superior, inferior, and nasal quadrants compared with values found in the same locations in the MAC group (P = 0.038, P = 0.011, and P = 0.014, respectively) (Fig. 7). In the G group, the BCE thickness was significantly higher in the inferior (53.9 ± 14.3 μm) and superior quadrants (53.2 ± 19.5 μm) compared with the temporal quadrant (44.6 ± 10.1 μm; P = 0.006 vs. inferior, and P = 0.038 vs. superior). However, no significant difference was found between the inferior or superior quadrants and the nasal region. The BCE thickness in the nasal quadrant was significantly higher in the G group compared with the MAC group (P = 0.010). 
Figure 7.
 
BCE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the BCE was thicker in the inferior (***P < 0.0001 vs. nasal and temporal) and the superior (**P = 0.020 vs. nasal and P < 0.0001 vs. temporal) quadrants. In the KCS group, the BCE was thicker in the superior, inferior, and nasal quadrants compared with the MAC group at the same quadrants (†P = 0.038, P = 0.011, and P = 0.014, respectively). In the G group, the BCE was thicker in the inferior (+P = 0.006 vs. temporal) and the superior (*P = 0.038 vs. temporal) quadrants. In the G group, the nasal BCE was thicker than the nasal BCE in the MAC group (‡P = 0.01).
Figure 7.
 
BCE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the BCE was thicker in the inferior (***P < 0.0001 vs. nasal and temporal) and the superior (**P = 0.020 vs. nasal and P < 0.0001 vs. temporal) quadrants. In the KCS group, the BCE was thicker in the superior, inferior, and nasal quadrants compared with the MAC group at the same quadrants (†P = 0.038, P = 0.011, and P = 0.014, respectively). In the G group, the BCE was thicker in the inferior (+P = 0.006 vs. temporal) and the superior (*P = 0.038 vs. temporal) quadrants. In the G group, the nasal BCE was thicker than the nasal BCE in the MAC group (‡P = 0.01).
Disease Severity Comparisons.
No correlation was observed between the ocular surface severity grades, the duration of glaucoma treatment, or the IOP, and the LE thickness in the KCS and G groups. In the KCS group, the mean BCE thickness was significantly higher in severity grades 3 and 4 (53.3 ± 12.1 μm) compared with grades 1 and 2 (45.7 ± 7.2 μm) (P = 0.031). No significant correlation could be observed between the ocular surface severity grades, glaucoma treatment, or the IOP, and the BCE thickness in the G group. 
Discussion
The thickness of the three ocular surface epithelia has been previously evaluated in vivo in normal subjects in one study using time-domain OCT. 15 The mean BCE, CE, and LE thicknesses were 44.9 ± 3.4 μm, 54.7 ± 1.9 μm, and 79.6 ± 7.4 μm, respectively. Similarly, using SD-OCT, we observed in normal subjects that the thinnest epithelium was in the BCE (42.0–42.2 μm) followed by the CE (48.3–48.8 μm), and the LE (83.0–84.3 μm). The CE of normal eyes has been evaluated in several studies using OCT, and a higher thickness than we measured has been reported (range: 52 μm to 81 μm). 7 14 The difference may be attributed to the fact that the other studies used time domain-OCT with an axial resolution of 8.1 to 20 μm, whereas the present study used SD-OCT (Spectralis OCT, Heidelberg Engineering GmbH) with anterior segment module and 3.9 μm axial resolution. A study that used a custom-built SD-OCT to measure CE thickness in normal subjects, 18 reported data (52 ± 2.4 μm) similar to our findings. The lower CE thickness observed in the present study may also be explained by the exclusion of the precorneal tear film (that measures 7 to 40 μm 19 ). Previous evaluations included the precorneal tear film because it could not be discriminated from the corneal epithelium. 
Previous studies evaluated epithelial thickness using the OCT intensity profile where the computer software-controlled cursors were manually placed at the peak of reflectivity corresponding to the tissue interfaces. 11,20 In the present study, considering the resolution of the OCT images obtained, we directly and manually placed the cursors provided by the SD-OCT software to measure epithelial thickness in each location. Similar to Wang et al., 11 we used the tear film as the first hyperreflective layer and the basal membrane as the second hyperreflective layer. Similar to Tao et al., 18 we found that the Bowman membrane was located between the second and the third hyperreflective layers (i.e., the second and the third peak of reflectivity). Our manual technique has some limitations, such as the placement of cursors precisely at tissue interfaces and obtaining a measurement perpendicular to the ocular surface. However, the computer-assisted image analysis of reflectivity profiles also utilizes the manual placement of a line perpendicular to the ocular surface structures and a manual measurement of the distance between reflectivity peaks. The aim of the present study was to evaluate using a simple method (that could be used in a clinical setting), the cross-sectional thickness of ocular surface epithelia and, despite its limitations, we obtained results similar to studies using a more complex image analysis system. 18  
The CE thickness was not statistically different between the YC and MAC groups. This observation is concordant with the results of previous IVCM studies that showed no alteration in epithelial cell density with age. 21,22 Similarly, there was no change in limbal or conjunctival thicknesses with age. No other studies have specifically evaluated LE thickness with regard to age, but analyses of the limbus with IVCM have revealed that the presence of Vogt palissades and limbal basal epithelial cells decline with age. 23,24 However, an age-related cell size enlargement 23,24 was also observed, which could explain, in part, the stability of the overall epithelial thickness observed using a cross-sectional imaging technique such as OCT. Interestingly, we observed a thicker LE in the superior and inferior regions of each group. These differences are similar to observations reported by Utheim et al., 25 who showed that human limbal epithelial explant of superior origin had high outgrowth success rate and generated epithelia. Also using confocal microscopy and scanning electron microscopy, Shortt et al. 26 showed more limbal crypts in the superior and inferior limbal regions. Wiley et al. 27 used immunofluorescence on corneal sections from donor eyes and found significant regional heterogeneity in the limbus, with a larger number of stem cells in the superior and inferior limbus than in the medial and lateral areas. Thus, the results demonstrate that patients with diseases implicating limbal stem cell deficiency may directly benefit from a noninvasive imaging technique that easily quantifies a parameter (LE thickness) representing or correlating with stem cell density. 
The BCE of healthy subjects did not reveal epithelial thickness changes related to age. Similarly, another study using IVCM analyzed conjunctival epithelial cell density and morphology, and did not find any difference between normal subjects of different ages. 28 Another study that used light and electron microscopy on conjunctival biopsies from elderly subjects reported no morphologic changes in BCE thickness, cell arrangement, or globlet cell count in subjects younger than 79 years old. 29  
Two different pathologies that alter ocular surface epithelia were evaluated in this study, namely dry eye 30,31 and eyes chronically treated for glaucoma or ocular hypertension with IOP-lowering eye drops. 4 There was no significant difference in the CE thicknesses between the KCS, G, and MAC groups. The CE changes in patients with dry eye or chronic treatment with preserved solutions remain under debate. In patients with dry eye, some authors using IVCM have observed a decreased epithelial cell density with a tendency to epithelial thinning, 32,33 whereas another researcher found no difference. 34 IVCM revealed that patients treated with preserved eye drops had a reduced density of corneal superficial epithelial cells and a higher density of basal epithelial cells compared with patients treated with preservative-free eye drops, or the untreated control group. 35 Although the current resolution of SD-OCT may not be sufficient to detect subtle changes in CE thickness, the absence of differences between the KCS, G, and MAC groups could be due to the relative lack of inflammatory cells and immune mediators in the cornea compared with the conjunctiva, rendering the cornea less sensitive to inflammatory changes. 36  
The LE was thinner in the KCS and the G groups compared with the MAC group. To our knowledge, no other in vivo investigation of LE thickness is available in patients with dry eye or in patients treated with IOP-lowering eye drops. These two conditions may induce limbus modifications through chronic inflammation or increased epithelial turnover. 37 The microenvironment of the limbus is considered to be important in maintaining the stemness and renewal of stem cells. 38,39 Limbal inflammatory conditions may decrease the number of limbal stem cells or alter their functions, resulting in varying degrees of stem cell deficiency. 40,41 Numerous studies highlight the inflammatory process in dry eye disease. 17,31 In patients with severe dry eye, a corneal conjunctivalization has been observed using IVCM, suggesting a stem cell deficiency. 42 Similarly, stem cell dysfunction and/or depletion due to eye drop toxicity could also partly explain the LE thinning in the G group. Schwartz and Holland 37,43 identified the concept of “iatrogenic limbal stem cell deficiency” in eyes treated with antiglaucoma eye drops. Thus, antiglaucoma eye drops and their preservatives, known to be toxic to the corneal and conjunctival epithelium, 4 could also be toxic to limbal epithelial cells, particularly stem cells. Limbal epithelial thinning as observed with SD-OCT might be the first landmark of these changes. 
In contrast to the LE, the BCE thickness was increased in the KCS and G groups compared with the MAC group. Moreover, in dry eye patients, there was a direct relationship between ocular surface disease severity and BCE thickness. In dry eye, this finding is confirmed by ex vivo studies. Kunert et al. 44 demonstrated an increased proliferative activity of the conjunctival epithelium from conjunctival biopsies of eyes with non-Sjögren dry eye. In patients with Sjögren syndrome-related dry eye, Jones et al. 45 observed abnormal proliferation and differentiation at the conjunctival epithelium. Wakamatsu et al. 36 observed with IVCM a decrease in the density of conjunctival epithelial cells in dry eye. However, an increase in epithelial cell size may explain the increased epithelial thickness in dry eye patients. Dry eye condition is associated with conjunctival squamous metaplasia. 46 Several studies using impression cytology or IVCM reported lower globlet cell density and epithelial cell enlargement associated with squamous metaplasia. 47 49 Interestingly, in the present study, the BCE of patients with dry eye was increased in the superior and inferior quadrants. This could be explained by the increased shear forces under the eyelids on a poorly lubricated ocular surface. 50  
An analysis of conjunctivial biopsies revealed a significant increase in BCE thickness and the number of conjunctival epithelial cell layers after topical antiglaucoma treatment. 51 Long-term antiglaucoma topical therapy was found to induce a significant decrease in goblet cells, and an increase in pale cells, macrophages, and lymphocytes within the epithelium. 52,53 Similar to dry eye, a squamous metaplasia has been reported (via impression cytology) after the use of topical antiglaucoma medications, 4 and might explain our findings. Interestingly, in the G group, the BCE thickness in the nasal quadrant—where the duration of contact between eye drop and ocular surface is prolonged—was significantly higher than in the MAC group. This may result in increased conjunctival irritation and consequently thickening of the BCE. 
Despite a lower resolution than IVCM, 54 SD-OCT has numerous advantages over other imaging techniques, such as slit-lamp or ultrasound biomicroscopy, for the evaluation of the ocular surface. OCT is a completely noninvasive imaging method that allows high-resolution analysis and measurements without the need of ocular anesthesia, water bath, or contact procedures. The epithelial thickness measurement of ocular surface tissues seems to be a new promising parameter, useful for the evaluation and grading of ocular surface disease severity. SD-OCT may not only improve our understanding of ocular surface diseases, but could also become a valuable tool in routine clinical practice to evaluate ocular surface epithelia. 
Footnotes
 Supported by Quinze-Vingts National Eye Center, Paris, France.
Footnotes
 Disclosure: M. Francoz, None; I. Karamoko, None; C. Baudouin, None; A. Labbé, None
References
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108–152. [CrossRef] [PubMed]
Singh R Joseph A Umapathy T Tint NL Dua HS . Impression cytology of the ocular surface. Br J Ophthalmol. 2005;89:1655–1659. [CrossRef] [PubMed]
Zhivov A Stachs O Kraak R Stave J Guthoff RF . In vivo confocal microscopy of the ocular surface. Ocul Surf. 2006;4:81–93. [CrossRef] [PubMed]
Baudouin C Labbe A Liang H Pauly A Brignole-Baudouin F . Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312–334. [CrossRef] [PubMed]
McLaren JW Nau CB Erie JC Bourne WM . Corneal thickness measurement by confocal microscopy, ultrasound, and scanning slit methods. Am J Ophthalmol. 2004;137:1011–1020. [CrossRef] [PubMed]
Huang D Swanson EA Lin CP . Optical coherence tomography. Science. 1991;254:1178–1181. [CrossRef] [PubMed]
Haque S Jones L Simpson T . Thickness mapping of the cornea and epithelium using optical coherence tomography. Optom Vis Sci. 2008;85:E963–E976. [CrossRef] [PubMed]
Sin S Simpson TL . The repeatability of corneal and corneal epithelial thickness measurements using optical coherence tomography. Optom Vis Sci. 2006;83:360–365. [CrossRef] [PubMed]
Feng Y Simpson TL . Comparison of human central cornea and limbus in vivo using optical coherence tomography. Optom Vis Sci. 2005;82:416–419. [CrossRef] [PubMed]
Wang J Fonn D Simpson TL Sorbara L Kort R Jones L . Topographical thickness of the epithelium and total cornea after overnight wear of reverse-geometry rigid contact lenses for myopia reduction. Invest Ophthalmol Vis Sci. 2003;44:4742–4746. [CrossRef] [PubMed]
Wang J Fonn D Simpson TL Jones L . The measurement of corneal epithelial thickness in response to hypoxia using optical coherence tomography. Am J Ophthalmol. 2002;133:315–319. [CrossRef] [PubMed]
Feng Y Varikooty J Simpson TL . Diurnal variation of corneal and corneal epithelial thickness measured using optical coherence tomography. Cornea. 2001;20:480–483. [CrossRef] [PubMed]
Radhakrishnan S Rollins AM Roth JE . Real-time optical coherence tomography of the anterior segment at 1310 nm. Arch Ophthalmol. 2001;119:1179–1185. [CrossRef] [PubMed]
Izatt JA Hee MR Swanson EA . Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol. 1994;112:1584–1589. [CrossRef] [PubMed]
Feng Y Simpson TL . Corneal, limbal, and conjunctival epithelial thickness from optical coherence tomography. Optom Vis Sci. 2008;85:E880–E883. [CrossRef] [PubMed]
Schiffman RM Christianson MD Jacobsen G Hirsch JD Reis BL . Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–621. [CrossRef] [PubMed]
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92. [CrossRef] [PubMed]
Tao A Wang J Chen Q . Topographical thickness of Bowman's layer determined by ultra-high resolution spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:3901–3907. [CrossRef] [PubMed]
Labbe A Brignole-Baudouin F Baudouin C . Ocular surface investigations in dry eye [in French]. J Fr Ophtalmol. 2007;30:76–97. [CrossRef] [PubMed]
Maldonado MJ Ruiz-Oblitas L Munuera JM Aliseda D Garcia-Layana A Moreno-Montanes J . Optical coherence tomography evaluation of the corneal cap and stromal bed features after laser in situ keratomileusis for high myopia and astigmatism. Ophthalmology. 2000;107:81–87; discussion 8. [CrossRef] [PubMed]
Niederer RL Perumal D Sherwin T McGhee CN . Age-related differences in the normal human cornea: a laser scanning in vivo confocal microscopy study. Br J Ophthalmol. 2007;91:1165–1169. [CrossRef] [PubMed]
Mustonen RK McDonald MB Srivannaboon S Tan AL Doubrava MW Kim CK . Normal human corneal cell populations evaluated by in vivo scanning slit confocal microscopy. Cornea. 1998;17:485–492. [CrossRef] [PubMed]
Zheng T Xu J . Age-related changes of human limbus on in vivo confocal microscopy. Cornea. 2008;27:782–786. [CrossRef] [PubMed]
Patel DV Sherwin T McGhee CN . Laser scanning in vivo confocal microscopy of the normal human corneoscleral limbus. Invest Ophthalmol Vis Sci. 2006;47:2823–2827. [CrossRef] [PubMed]
Utheim TP Raeder S Olstad OK . Comparison of the histology, gene expression profile, and phenotype of cultured human limbal epithelial cells from different limbal regions. Invest Ophthalmol Vis Sci. 2009;50:5165–5172. [CrossRef] [PubMed]
Shortt AJ Secker GA Munro PM Khaw PT Tuft SJ Daniels JT . Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells. 2007;25:1402–1409. [CrossRef] [PubMed]
Wiley L SundarRaj N Sun TT Thoft RA . Regional heterogeneity in human corneal and limbal epithelia: an immunohistochemical evaluation. Invest Ophthalmol Vis Sci. 1991;32:594–602. [PubMed]
Zhu W Hong J Zheng T Le Q Xu J Sun X . Age-related changes of human conjunctiva on in vivo confocal microscopy. Br J Ophthalmol. 2010;94:1448–1453. [CrossRef] [PubMed]
Abdel-Khalek LM Williamson J Lee WR . Morphological changes in the human conjunctival epithelium. I. In the normal elderly population. Br J Ophthalmol. 1978;62:792–799. [CrossRef] [PubMed]
Reinoso R Calonge M Castellanos E . Differential cell proliferation, apoptosis, and immune response in healthy and evaporative-type dry eye conjunctival epithelia. Invest Ophthalmol Vis Sci. 2011;52:4819–4828. [CrossRef] [PubMed]
Brignole F Pisella PJ Goldschild M De Saint Jean M Goguel A Baudouin C . Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356–1363. [PubMed]
Erdelyi B Kraak R Zhivov A Guthoff R Nemeth J . In vivo confocal laser scanning microscopy of the cornea in dry eye. Graefes Arch Clin Exp Ophthalmol. 2007;245:39–44. [CrossRef] [PubMed]
Villani E Galimberti D Viola F Mapelli C Ratiglia R . The cornea in Sjogren's syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48:2017–2022. [CrossRef] [PubMed]
Tuominen IS Konttinen YT Vesaluoma MH Moilanen JA Helinto M Tervo TM . Corneal innervation and morphology in primary Sjogren's syndrome. Invest Ophthalmol Vis Sci. 2003;44:2545–2549. [CrossRef] [PubMed]
Martone G Frezzotti P Tosi GM . An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol. 2009;147:725–735, e1. [CrossRef] [PubMed]
Wakamatsu TH Sato EA Matsumoto Y . Conjunctival in vivo confocal scanning laser microscopy in patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2010;51:144–150. [CrossRef] [PubMed]
Schwartz GS Holland EJ . Iatrogenic limbal stem cell deficiency. Cornea. 1998;17:31–37. [CrossRef] [PubMed]
Schlotzer-Schrehardt U Dietrich T Saito K . Characterization of extracellular matrix components in the limbal epithelial stem cell compartment. Exp Eye Res. 2007;85:845–860. [CrossRef] [PubMed]
Cotsarelis G Cheng SZ Dong G Sun TT Lavker RM . Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57:201–209. [CrossRef] [PubMed]
Puangsricharern V Tseng SC . Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102:1476–1485. [CrossRef] [PubMed]
Dua HS Azuara-Blanco A . Limbal stem cells of the corneal epithelium. Surv Ophthalmol. 2000;44:415–425. [CrossRef] [PubMed]
De Nicola R Labbe A Amar N Dupas B Baudouin C . In vivo confocal microscopy and ocular surface diseases: anatomical-clinical correlations [in French]. J Fr Ophtalmol. 2005;28:691–698. [CrossRef] [PubMed]
Schwartz GS Holland EJ . Iatrogenic limbal stem cell deficiency: when glaucoma management contributes to corneal disease. J Glaucoma. 2001;10:443–445. [CrossRef] [PubMed]
Kunert KS Tisdale AS Gipson IK . Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120:330–337. [CrossRef] [PubMed]
Jones DT Monroy D Ji Z Pflugfelder SC . Alterations of ocular surface gene expression in Sjogren's syndrome. Adv Exp Med Biol. 1998;438:533–536. [PubMed]
Lopin E Deveney T Asbell PA . Impression cytology: recent advances and applications in dry eye disease. Ocul Surf. 2009;7:93–110. [CrossRef] [PubMed]
Kojima T Matsumoto Y Dogru M Tsubota K . The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. Mol Vis. 2010;16:2457–2464. [PubMed]
Nelson JD . Impression cytology. Cornea. 1988;7:71–81. [CrossRef] [PubMed]
Tseng SC . Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92:728–733. [CrossRef] [PubMed]
Stern ME Beuerman RW Fox RI Gao J Mircheff AK Pflugfelder SC . The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–589. [CrossRef] [PubMed]
Nuzzi R Vercelli A Finazzo C Cracco C . Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233:154–162. [CrossRef] [PubMed]
Sherwood MB Grierson I Millar L Hitchings RA . Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327–335. [CrossRef] [PubMed]
Broadway DC Grierson I O'Brien C Hitchings RA . Adverse effects of topical antiglaucoma medication, I: the conjunctival cell profile. Arch Ophthalmol. 1994;112:1437–1445. [CrossRef] [PubMed]
Guthoff RF Zhivov A Stachs O . In vivo confocal microscopy, an inner vision of the cornea - a major review. Clin Experiment Ophthalmol. 2009;37:100–117. [CrossRef] [PubMed]
Figure 1.
 
SD-OCT images of ocular surface epithelia. (A–C) CE analysis. (A) Live cSLO image of the central cornea with the horizontal scan mark; (B) corresponding SD-OCT (B-scan); the white rectangle shows the area analyzed; (C) CE thickness measurement with software cursors, the tear film appears hyperreflective (white arrow) and the basal epithelial membrane appeared hyperreflective (black arrow). (D–F) Limbal epithelium (LE) analysis. (D) Live cSLO image, the black arrow marks the vertical line on SD-OCT; (E) corresponding SD-OCT image; the vertical line was centered on the limbus through the scleral spur; (F) LE thickness measures. (G–I) BCE analysis. (G) Live cSLO image; (H) corresponding SD-OCT image; the white rectangle shows the bulbar conjunctival zone between 2 and 3 mm from limbus (vertical line); (I) BCE thickness measures.
Figure 1.
 
SD-OCT images of ocular surface epithelia. (A–C) CE analysis. (A) Live cSLO image of the central cornea with the horizontal scan mark; (B) corresponding SD-OCT (B-scan); the white rectangle shows the area analyzed; (C) CE thickness measurement with software cursors, the tear film appears hyperreflective (white arrow) and the basal epithelial membrane appeared hyperreflective (black arrow). (D–F) Limbal epithelium (LE) analysis. (D) Live cSLO image, the black arrow marks the vertical line on SD-OCT; (E) corresponding SD-OCT image; the vertical line was centered on the limbus through the scleral spur; (F) LE thickness measures. (G–I) BCE analysis. (G) Live cSLO image; (H) corresponding SD-OCT image; the white rectangle shows the bulbar conjunctival zone between 2 and 3 mm from limbus (vertical line); (I) BCE thickness measures.
Figure 2.
 
Comparisons between CE, LE, and BCE thicknesses in YC group and MAC group. In both groups, the thickest epithelium was the LE followed by the CE (***P < 0.0001 in both groups, comparing LE with CE) and BCE (*P = 0.003 in YC and **P = 0.019 in MAC comparing BCE with CE). There was no statistical difference in CE, LE, and BCE thickness between the YC and MAC groups.
Figure 2.
 
Comparisons between CE, LE, and BCE thicknesses in YC group and MAC group. In both groups, the thickest epithelium was the LE followed by the CE (***P < 0.0001 in both groups, comparing LE with CE) and BCE (*P = 0.003 in YC and **P = 0.019 in MAC comparing BCE with CE). There was no statistical difference in CE, LE, and BCE thickness between the YC and MAC groups.
Figure 3.
 
LE thickness in each quadrant in YC and MAC groups. In the YC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001). In the MAC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001).
Figure 3.
 
LE thickness in each quadrant in YC and MAC groups. In the YC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001). In the MAC group, the LE was thicker in the inferior and superior quadrants compared with the nasal and temporal quadrants (*P < 0.0001).
Figure 4.
 
BCE thickness in each quadrant in YC and MAC groups. In the YC group, the BCE was thicker in the inferior quadrant (*P = 0.03 vs. nasal, P < 0.0001 vs. temporal, P = 0.009 vs. superior). In the MAC group, there was no significant difference between each quadrant.
Figure 4.
 
BCE thickness in each quadrant in YC and MAC groups. In the YC group, the BCE was thicker in the inferior quadrant (*P = 0.03 vs. nasal, P < 0.0001 vs. temporal, P = 0.009 vs. superior). In the MAC group, there was no significant difference between each quadrant.
Figure 5.
 
Comparison between mean CE, LE, and BCE thicknesses in KCS, G, and MAC groups. In the KCS and MAC groups, the thickest epithelium was the LE (+P < 0.0001 LE compared with CE and BCE). The mean LE was significantly thinner in the KCS group (*P = 0.031) and in the G group (**P = 0.001) compared with the MAC group. The mean BCE was thicker in the KCS group (†P = 0.005) and in the G group (‡P = 0.017) compared with the MAC group.
Figure 5.
 
Comparison between mean CE, LE, and BCE thicknesses in KCS, G, and MAC groups. In the KCS and MAC groups, the thickest epithelium was the LE (+P < 0.0001 LE compared with CE and BCE). The mean LE was significantly thinner in the KCS group (*P = 0.031) and in the G group (**P = 0.001) compared with the MAC group. The mean BCE was thicker in the KCS group (†P = 0.005) and in the G group (‡P = 0.017) compared with the MAC group.
Figure 6.
 
LE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the LE was thicker in the inferior quadrant (+P = 0.026 vs. nasal and P < 0.0001 vs. temporal) and the superior quadrant (***P < 0.0001 vs. nasal and temporal). In the KCS group, the inferior LE was thinner than the inferior LE of the MAC group (‡P = 0.0018). In the G group, the LE was thicker in the inferior quadrant (**P < 0.0001 vs. nasal and temporal) and the superior quadrant (**P < 0.0001 vs. nasal and temporal). Compared with the MAC group, the G group had thinner LE in the inferior and superior quadrants (†P = 0.001 and P = 0.008 respectively). In the MAC group, the LE was thicker in the inferior quadrant (*P < 0.0001 vs. nasal and temporal) and the superior quadrant (*P < 0.0001 vs. nasal and temporal).
Figure 6.
 
LE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the LE was thicker in the inferior quadrant (+P = 0.026 vs. nasal and P < 0.0001 vs. temporal) and the superior quadrant (***P < 0.0001 vs. nasal and temporal). In the KCS group, the inferior LE was thinner than the inferior LE of the MAC group (‡P = 0.0018). In the G group, the LE was thicker in the inferior quadrant (**P < 0.0001 vs. nasal and temporal) and the superior quadrant (**P < 0.0001 vs. nasal and temporal). Compared with the MAC group, the G group had thinner LE in the inferior and superior quadrants (†P = 0.001 and P = 0.008 respectively). In the MAC group, the LE was thicker in the inferior quadrant (*P < 0.0001 vs. nasal and temporal) and the superior quadrant (*P < 0.0001 vs. nasal and temporal).
Figure 7.
 
BCE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the BCE was thicker in the inferior (***P < 0.0001 vs. nasal and temporal) and the superior (**P = 0.020 vs. nasal and P < 0.0001 vs. temporal) quadrants. In the KCS group, the BCE was thicker in the superior, inferior, and nasal quadrants compared with the MAC group at the same quadrants (†P = 0.038, P = 0.011, and P = 0.014, respectively). In the G group, the BCE was thicker in the inferior (+P = 0.006 vs. temporal) and the superior (*P = 0.038 vs. temporal) quadrants. In the G group, the nasal BCE was thicker than the nasal BCE in the MAC group (‡P = 0.01).
Figure 7.
 
BCE thickness in each quadrant in KCS, G, and MAC groups. In the KCS group, the BCE was thicker in the inferior (***P < 0.0001 vs. nasal and temporal) and the superior (**P = 0.020 vs. nasal and P < 0.0001 vs. temporal) quadrants. In the KCS group, the BCE was thicker in the superior, inferior, and nasal quadrants compared with the MAC group at the same quadrants (†P = 0.038, P = 0.011, and P = 0.014, respectively). In the G group, the BCE was thicker in the inferior (+P = 0.006 vs. temporal) and the superior (*P = 0.038 vs. temporal) quadrants. In the G group, the nasal BCE was thicker than the nasal BCE in the MAC group (‡P = 0.01).
Table 1.
 
Ocular Surface Epithelium Thickness (μm) in Normal Eyes, in Dry Eyes (KCS Group), and in Eyes Treated Chronically with IOP-Lowering Eyedrops (G group)
Table 1.
 
Ocular Surface Epithelium Thickness (μm) in Normal Eyes, in Dry Eyes (KCS Group), and in Eyes Treated Chronically with IOP-Lowering Eyedrops (G group)
Ocular Surface Epithelium Young Controls Middle-Aged Controls KCS G
CE 48.3 ± 2.9 48.8 ± 3.0 49.0 ± 4.1 50.3 ± 5.7
LE 83.0 ± 14.3 84.3 ± 10.1 77.3 ± 17.2 73.3 ± 10.5
Nasal 67.9 ± 10.7 67.9 ± 7.5 65.0 ± 14.9 68.0 ± 16.1
Temporal 69.3 ± 14.5 66.9 ± 11.9 63.6 ± 15.0 62.4 ± 13.6
Inferior 98.0 ± 23.7 106.8 ± 20.0 86.1 ± 21.6 80.3 ± 20.1
Superior 95.6 ± 15.0 97.2 ± 11.1 95.9 ± 35.4 83.9 ± 18.4
BCE 42.0 ± 7.5 42.2 ± 7.9 50.4 ± 11.1 49.5 ± 11.0
Nasal 41.1 ± 8.2 39.1 ± 9.1 46.3 ± 11.0 48.2 ± 12.4
Temporal 38.3 ± 7.7 41.3 ± 9.8 43.6 ± 11.6 44.6 ± 10.1
Inferior 47.3 ± 11.9 47.7 ± 15.0 55.2 ± 9.6 53.9 ± 14.3
Superior 40.4 ± 8.9 43.6 ± 11.7 58.0 ± 27.5 53.2 ± 19.5
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×